The neuropsychiatry of multiple sclerosis

被引:148
作者
Feinstein, A [1 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON M4N 3M5, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2004年 / 49卷 / 03期
关键词
multiple sclerosis; mood; cognition; neuroimaging; translational research; treatment;
D O I
10.1177/070674370404900302
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This review describes the many neuropsychiatric abnormalities associated with multiple sclerosis (MS). These may be broadly divided into 2 categories: disorders of mood, affect, and behaviour and abnormalities affecting cognition. With respect to the former, the epidemiology, phenomenology, and theories of etiology are described for the syndromes of depression, bipolar disorder, euphoria, pathological laughing and crying, and psychosis attributable to MS. The section discussing cognition reviews the prevalence and nature of cognitive dysfunction, with an emphasis on abnormalities affecting multiple domains of memory, speed of information processing, and executive function. The detection, natural history, and cerebral correlates of cognitive dysfunction are also discussed. Finally, treatment pertaining to all these disorders is reviewed, with the observation that translational research has been found wanting when it comes to providing algorithms to guide clinicians. Guidelines derived from general psychiatry still largely apply, although they may not always be most effective in patients with neurologic disorders. The importance of future research addressing this imbalance is emphasized, for neuropsychiatric sequelae add significantly to the morbidity associated with MS.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 76 条
[1]   RELATIONSHIP BETWEEN FRONTAL-LOBE LESIONS AND WISCONSIN CARD SORTING TEST-PERFORMANCE IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
ARNETT, PA ;
RAO, SM ;
BERNARDIN, L ;
GRAFMAN, J ;
YETKIN, FZ ;
LOBECK, L .
NEUROLOGY, 1994, 44 (03) :420-425
[2]   Brain MRI lesions and atrophy are related to depression in multiple sclerosis [J].
Bakshi, R ;
Czarnecki, D ;
Shaikh, ZA ;
Priore, RL ;
Janardhan, V ;
Kaliszly, Z ;
Kinkel, PR .
NEUROREPORT, 2000, 11 (06) :1153-1158
[3]   Moclobemide treatment in multiple sclerosis patients with comorbid depression: An open-label safety trial [J].
Barak, Y ;
Ur, E ;
Achiron, A .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (02) :271-273
[4]   Screening for cognitive dysfunction in multiple sclerosis [J].
Basso, MR ;
BeasonHazen, S ;
Lynn, J ;
Rammohan, K ;
Bornstein, RA .
ARCHIVES OF NEUROLOGY, 1996, 53 (10) :980-984
[5]  
Beatty W W, 1996, J Int Neuropsychol Soc, V2, P134
[6]   ANTEROGRADE AND RETROGRADE-AMNESIA IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
BEATTY, WW ;
GOODKIN, DE ;
MONSON, N ;
BEATTY, PA ;
HERTSGAARD, D .
ARCHIVES OF NEUROLOGY, 1988, 45 (06) :611-619
[7]   METAMEMORY IN MULTIPLE-SCLEROSIS [J].
BEATTY, WW ;
MONSON, N .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1991, 13 (02) :309-327
[8]   SCREENING FOR COGNITIVE IMPAIRMENT IN MULTIPLE-SCLEROSIS - AN EVALUATION OF THE MINI-MENTAL STATE EXAMINATION [J].
BEATTY, WW ;
GOODKIN, DE .
ARCHIVES OF NEUROLOGY, 1990, 47 (03) :297-301
[9]   Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire [J].
Benedict, RHB ;
Munschauer, F ;
Linn, R ;
Miller, C ;
Murphy, E ;
Foley, F ;
Jacobs, L .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (01) :95-101
[10]  
CHAMELIAN L, 2003, J NEUROPSYCHIATRY CL, V15, P260